Burning Rock Biotech Ltd SEC filings BNR
Burning Rock Biotech Ltd has 169 filings in SEC EDGAR's recent list, going back to Nov 4, 2019. Its latest annual report, Form 20-F, was filed on Apr 28, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Sep 10, 2026.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B3 | Prospectus | Sep 18, 2024 | — |
| F-6 POS | Filing | Apr 26, 2024 | — |
| 424B5 | Prospectus supplement | Nov 7, 2022 | — |
| F-6 POS | Filing | Oct 31, 2022 | — |
| F-3/A | Amendment no. 5 to form f-3 | Sep 28, 2022 | — |
| F-3/A | Amendment no. 4 to form f-3 | Sep 20, 2022 | — |
| F-3/A | Amendment no. 3 to form f-3 | Sep 12, 2022 | — |
| F-3/A | Amendment no.2 to form f-3 | Aug 16, 2022 | — |
| F-3/A | Amendment no.1 to form f-3 | Jun 21, 2022 | — |
| F-3 | Shelf registration (foreign issuer) | Apr 29, 2022 | — |
| S-8 | Employee stock plan registration | Dec 8, 2020 | — |
| 424B4 | Prospectus | Dec 4, 2020 | — |
| F-1MEF | Filing | Dec 3, 2020 | — |
| F-1/A | Amendment no.1 to form f-1 | Dec 2, 2020 | — |
| F-1 | Registration statement (foreign issuer) | Dec 1, 2020 | — |
| 424B4 | Prospectus | Jun 12, 2020 | — |
| F-1/A | Amendment no.2 to form f-1 | Jun 8, 2020 | — |
| FWP | Free writing prospectus | Jun 8, 2020 | — |
| F-1/A | Amendment no.1 to form f-1 | Jun 5, 2020 | — |
| F-6 | Filing | Jun 3, 2020 | — |
| F-1 | Registration statement (foreign issuer) | May 22, 2020 | — |
Showing 21 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Services-Medical Laboratories (SIC 8071)
- Listed as
- BNR (Nasdaq)
- Headquarters
- Guangzhou, Guangdong
- SEC filer status
- Non-accelerated filer
- SEC CIK
- 1792267
Other Services-Medical Laboratories companies
- Natera, Inc. NTRA
- Labcorp Holdings Inc. LH
- Quest Diagnostics Inc DGX
- Guardant Health, Inc. GH
- Caris Life Sciences, Inc. CAI
- GRAIL, Inc. GRAL
- RadNet, Inc. RDNT
- BillionToOne, Inc. BLLN
Source: SEC EDGAR filings. This is company-reported data, not investment advice.